The role of viral and host genes in corneal infection with herpes simplex virus type 1

Al-Kobaisi, 1991, The herpes simplex virus UL33 gene product is required for the assembly of full capsids, Virology, 180, 380, 10.1016/0042-6822(91)90043-B Babu, 1996, Viral replication is required for induction of ocular immunopathology by herpes simplex virus, J. Virol., 70, 101, 10.1128/JVI.70.1.101-107.1996 Balish, 1992, Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-α and -γ, J. Infect. Dis., 166, 1401, 10.1093/infdis/166.6.1401 Brandt, 1991, Mixed ocular infections identify strains of herpes simplex virus for use in genetic studies, J. Virol. Methods, 35, 127, 10.1016/0166-0934(91)90128-M Brandt, 1992, Susceptibility of +/+, +/nu and nu/nu BALB/c mice to ocular herpes simplex virus infection, Ophthalmic Res., 24, 332, 10.1159/000267189 Brandt, 1990, Mixed infection with herpes simplex virus type 1 generates recombinants with increased ocular and neurovirulence, Invest. Ophthalmol. Vis. Sci., 31, 2214 Brandt, 2003, Tyrosine 116 of the herpes simplex virus IEa22 protein is an ocular virulence determinant and potential phosphorylation site, Invest. Ophthalmol. Vis. Sci., 44, 4601, 10.1167/iovs.03-0582 Brandt, 1991, The herpes simplex virus ribonucleotide reductase is required for ocular virulence, J. Gen. Virol., 72, 2043, 10.1099/0022-1317-72-9-2043 Brandt, 1992, A murine model of herpes simplex virus-induced ocular disease for antiviral drug testing, J. Virol. Methods, 36, 209, 10.1016/0166-0934(92)90052-F Brandt, 1996, Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of Herpes simplex virus type 1 ocular disease, Antimicrob. Agents Chemother., 40, 1078, 10.1128/AAC.40.5.1078 Brandt, 2003, Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant, Invest. Ophthalmol. Vis. Sci., 44, 2657, 10.1167/iovs.02-1105 Cai, 1993, The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency, J. Virol., 67, 7501, 10.1128/JVI.67.12.7501-7512.1993 Cantin, 1992, Persistence of herpes simplex virus DNA in rabbit corneal cells, Invest. Ophthalmol. Vis. Sci., 33, 2470 Carr, 2001, The immune response to ocular herpes simplex virus type 1 infection, Exp. Biol. Med., 226, 353, 10.1177/153537020122600501 Centifanto-Fitzgerald, 1982, Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA, J. Exp. Med., 155, 475, 10.1084/jem.155.2.475 Chou, 1990, Mapping of herpes simplex virus-I neurovirulence to γ1-34.5, a gene nonessential for growth in culture, Science, 250, 1262, 10.1126/science.2173860 Daheshia, 1998, Production of key molecules by ocular neutrophils early after herpetic infection of the cornea, Exp. Eye Res., 67, 619, 10.1006/exer.1998.0565 Desai, 1998, Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid, J. Virol., 72, 7563, 10.1128/JVI.72.9.7563-7568.1998 Deshpande, 2001, Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis, J. Virol., 75, 3077, 10.1128/JVI.75.7.3077-3088.2001 Doymaz, 1992, Immunopathology of herpes simplex virus infections, Curr. Topics Microbiol. Immunol., 179, 121 Elliott, 1999, Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection, J. Virol., 73, 4110, 10.1128/JVI.73.5.4110-4119.1999 Ellison, 2003, Analysis of the herpes simplex virus type 1 UL6 gene in patients with stromal keratitis, Virology, 310, 24, 10.1016/S0042-6822(03)00075-8 Everett, 2000, ICP0, a regulator of herpes simplex virus during lytic and latent infection, Bioessays, 22, 761, 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A Feenstra, 1992, Comparison of fluorescein and rose bengal staining, Ophthalmology, 99, 605, 10.1016/S0161-6420(92)31947-5 Field, 1986, Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene, J. Virol., 60, 286, 10.1128/JVI.60.1.286-289.1986 Field, 1978, The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice, J. Hyg., 81, 267, 10.1017/S0022172400025109 Fujihara, 1995, Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea, Arch. Virol., 140, 1469, 10.1007/BF01322673 Ghiasi, 1997, Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations, Invest. Ophthalmol. Vis. Sci., 38, 1213 Goldstein, 1988, Factor(s) present in Herpes simplex virus Type 1—infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant, Virology, 166, 41, 10.1016/0042-6822(88)90144-4 Goldstein, 1988, Herpes simplex virus Type-1 ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant, J. Virol., 62, 196, 10.1128/JVI.62.1.196-205.1988 Gordon, 1983, HSV-1 thymidine kinase promotes virulence and latency in the mouse, Invest. Ophthalmol. Vis. Sci., 24, 599 Gordon, 1990, A herpes simplex type I ICPO deletion mutant demonstrates diminished pathogenicity during acute ocular infection in different host animals, Invest. Ophthalmol. Vis. Sci., 31, 681 Gordon, 1991, Herpes simplex virus-I corneal latency, Invest. Ophthalmol. Vis. Sci., 32, 663 Grau, 1989, Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence, Invest. Ophthalmol. Vis. Sci., 30, 2474 Han, 2001, Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice, J. Virol., 75, 3048, 10.1128/JVI.75.6.3048-3052.2001 He, 1997, Proc. Natl Acad. Sci. USA, 94, 843, 10.1073/pnas.94.3.843 He, 1998, The γ134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells, J. Biol. Chem., 273, 20737, 10.1074/jbc.273.33.20737 He, 1999, Kinetics of cytokine production in the corneal and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection, J. Interferon Cytokine Res., 19, 609, 10.1089/107999099313749 Hendricks, 1991, Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease, J. Gen. Virol., 72, 1601, 10.1099/0022-1317-72-7-1601 Herold, 1991, Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity, J. Virol., 65, 1090, 10.1128/JVI.65.3.1090-1098.1991 Horsburgh, 1999, Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes, Gene Ther., 6, 922, 10.1038/sj.gt.3300887 Hukkanen, 2002, Cytokines in experimental herpes simplex virus infection, Int. Rev. Immunol., 21, 355, 10.1080/08830180213276 Javier, 1987, Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence, J. Virol., 61, 1978, 10.1128/JVI.61.6.1978-1984.1987 Kastrukoff, 1986, Genetics of natural resistance to herpes simplex virus type I latent infection of the peripheral nervous system in mice, J. Gen. Virol., 67, 613, 10.1099/0022-1317-67-4-613 Keadle, 2000, IL-1 and TNF-α are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis, Invest. Ophthalmol. Vis. Sci., 41, 96 Kintner, 1995, The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection, Curr. Eye Res., 14, 145, 10.3109/02713689508999926 Kobelt, 2003, The interaction between dendritic cells and herpes simplex virus-1, Curr. Topics Microbiol. Immunol., 276, 145 Koelle, 2003, Recent progress in herpes simplex virus immunobiology and vaccine research, Clin. Microbiol. Rev., 16, 96, 10.1128/CMR.16.1.96-113.2003 Koelle, 2000, Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans, J. Virol., 74, 10930, 10.1128/JVI.74.23.10930-10938.2000 Kolb, 2004, Enhanced isolation of low frequency herpes simplex virus recombinants using green-fluorescent protein and FACS, J. Virol. Methods, 115, 73, 10.1016/j.jviromet.2003.09.017 Langelier, 1998, The R1 subunit of herpes simplex virus ribonucleotide reductase is a good substrate for host cell protein kinases but is not itself a protein kinase, J. Biol. Chem., 273, 1435, 10.1074/jbc.273.3.1435 Leib, 2002, Counteraction of interferon-induced antiviral responses by herpes simplex virus, Curr. Topics Microbiol. Immunol., 269, 171 Leib, 1999, Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo, J. Exp. Med., 189, 663, 10.1084/jem.189.4.663 Liesegang, 2001, Herpes simplex virus epidemiology and ocular importance, Cornea, 20, 1, 10.1097/00003226-200101000-00001 Lopez, 1975, Genetics of natural resistance to herpes virus infections in mice, Nature, 258, 152, 10.1038/258152a0 Lubinski, 1999, In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC, J. Exp. Med., 190, 1637, 10.1084/jem.190.11.1637 Lundberg, 2003, A potential role for CXCR3 chemokines in the response to ocular HSV infection, Curr. Eye Res., 26, 137, 10.1076/ceyr.26.3.137.14898 Lundberg, 2003, A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mouse, J. Virol., 77, 11661, 10.1128/JVI.77.21.11661-11673.2003 Maggs, 1998, Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions in mice, J. Virol., 72, 9166, 10.1128/JVI.72.11.9166-9172.1998 McGeoch, 1988, The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1, J. Gen. Virol., 69, 1531, 10.1099/0022-1317-69-7-1531 McNabb, 1992, Analysis of the UL36 open reading frame encoding the large tegument protein (ICP1/2) of herpes simplex virus type 1, J. Virol., 66, 7581, 10.1128/JVI.66.12.7581-7584.1992 McNabb, 1992, Characterization of the large tegument protein (ICP1/2) of herpes simplex virus type 1, Virology, 190, 221, 10.1016/0042-6822(92)91208-C Metcalf, 1984, Herpetic keratitis in inbred mice, Invest. Ophthalmol. Vis. Sci., 25, 1222 Meyers-Elliott, 1981, Immunopathogenesis of corneal inflammation in herpes simplex virus stromal keratitis: role of the polymorphonuclear leukocyte, Invest. Ophthalmol. Vis. Sci., 20, 784 Mitchell, 1994, Casein kinase II specifically nucleotidylylates in vitro the amino acid sequence of the protein encoded by the (22 gene of herpes simplex virus 1, Proc. Natl Acad. Sci. USA, 91, 11864, 10.1073/pnas.91.25.11864 Miyazaki, 1997, Neutrophil chemotaxis induced by corneal epithelial cells after herpes simplex virus type 1 infection, Curr. Eye Res., 17, 687, 10.1080/02713689808951244 Mossman, 2000, Herpes simplex virus ICP0 mutants are hypersensitive to interferon, J. Virol., 74, 2052, 10.1128/JVI.74.4.2052-2056.2000 Mulvey, 2003, Regulation of eIF2α phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle, J. Virol., 77, 10917, 10.1128/JVI.77.20.10917-10928.2003 Norose, 2002, Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers, J. Virol., 76, 3502, 10.1128/JVI.76.7.3502-3510.2002 Oakes, 1993, Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells, J. Virol., 63, 769 O'Brien, 1989, The isolation of herpes simplex virus from rabbit corneas during latency, Invest. Ophthalmol. Vis. Sci., 30, 357 O'Brien, 1990, Pathogenesis of corneal oedema associated with herpetic eye disease, Br. J. Ophthalmol., 74, 723, 10.1136/bjo.74.12.723 O'Brien, 1998, Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits, Invest. Ophthalmol. Vis. Sci., 39, 1847 Opremcak, 1988, Immunogenetic influence of Igh-1 phenotype on experimental herpes simple virus type-1 corneal infection, Invest. Ophthalmol. Vis. Sci., 29, 749 O'Toole, 2003, Mutation of the protein tyrosine kinase consensus site in the herpes simplex virus 1 α22 gene alters ICP22 posttranslational modification, Virology, 305, 153, 10.1006/viro.2002.1746 Peng, 1996, The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2, Virology, 216, 184, 10.1006/viro.1996.0045 Poffenberger, 1994, A herpes simplex virus type 1 ICP22 deletion mutant is altered for virulence and latency in vivo, Arch. Virol., 139, 111, 10.1007/BF01309458 Pollara, 2004, The host response to herpes simplex virus infection, Curr. Opin. Infect. Dis., 17, 199, 10.1097/00001432-200406000-00005 Post, 1981, A generalized technique for deletion of specific genes in large genomes: α gene 22 of herpes simplex virus 1 is not essential for growth, Cell, 25, 227, 10.1016/0092-8674(81)90247-6 Purves, 1992, The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein α22, Proc. Natl Acad. Sci. USA, 89, 7310, 10.1073/pnas.89.16.7310 Reynolds, 2000, Characterization of the UL33 gene product of herpes simplex virus 1, Virology, 266, 310, 10.1006/viro.1999.0090 Roizman, 2001, Herpes simplex viruses and their replication, 2399 Roizman, 1996, Herpes simplex viruses and their replication, 2231 Rong, 1991, Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification, Invest. Ophthalmol. Vis. Sci., 32, 1808 Schmitz, 1995, The UL37 protein of herpes simplex virus type 1 is associated with the tegument of purified virions, Virology, 206, 1055, 10.1006/viro.1995.1028 Sears, 1985, Herpes simplex virus 1 mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice, J. Virol., 55, 338, 10.1128/JVI.55.2.338-346.1985 Shelton, 1990, Identification and characterization of the herpes simplex virus type 1 protein encoded by the UL37 open reading frame, J. Virol., 64, 6101, 10.1128/JVI.64.12.6101-6109.1990 Smith, 1997, The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP0) is associated with the virion tegument and has PK activity, Virology, 234, 235, 10.1006/viro.1997.8645 Smith, 2000, Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice, J. Virol., 74, 3598, 10.1128/JVI.74.8.3598-3604.2000 Spear, 1993, Entry of alphaherpesviruses into cells, Semin. Virol., 4, 167, 10.1006/smvy.1993.1012 Streilein, 1997, Immunity causing blindness: five different paths to herpes stromal keratitis, Immunol. Today, 18, 443, 10.1016/S0167-5699(97)01114-6 Strelow, 1996, Analysis of conserved domains of UL41 of herpes simplex virus type 1 in virion host shutoff and pathogenesis, J. Virol., 70, 5665, 10.1128/JVI.70.8.5665-5667.1996 Stulting, 1985, Patterns of herpes simplex keratitis in inbred mice, Invest. Ophthalmol. Vis. Sci., 26, 1360 Stumpf, 2001, Cytokine production in a murine model of recurrent herpetic stromal keratitis, Invest. Ophthalmol. Vis. Sci., 42, 372 Su, 1996, Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection, J. Virol., 70, 1277, 10.1128/JVI.70.2.1277-1281.1996 Subak-Sharpe, 1977, Genetics of herpes viruses, 89 Tanaka, 2003, Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus Type 1: viruses reconstituted from the clone exhibit wild-type properties in vivo and in vitro, J. Virol., 77, 1382, 10.1128/JVI.77.2.1382-1391.2003 Tang, 1996, Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas, J. Exp. Med., 184, 1435, 10.1084/jem.184.4.1435 Thomas, 1997, Immunopathogenesis of herpetic ocular disease, Immunol. Res., 16, 375, 10.1007/BF02786400 Thompson, 1983, Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent, Virology, 131, 171, 10.1016/0042-6822(83)90543-3 Torres, 2001, The role of cytokines in corneal immunopathology, Ocular Immunol. Inflamm., 9, 9, 10.1076/ocii.9.1.9.3978 Trgovcich, 2002, Cell surface major histocompatibility complex class II proteins are regulated by the products of the γ134.5 and UL41 genes of herpes simplex virus 1, J. Virol., 76, 6974, 10.1128/JVI.76.14.6974-6986.2002 Tumpey, 1998, Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis, J. Virol., 72, 3705, 10.1128/JVI.72.5.3705-3710.1998 Tumpey, 2002, Role for macrophage inflammatory protein 2 (MIP-2), MIP-1α, and interleukin-1α in the delayed-type hypersensitivity response to viral antigen, J. Virol., 76, 8050, 10.1128/JVI.76.16.8050-8057.2002 Verjans, 1998, Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients, J. Infect. Dis., 177, 484, 10.1086/517382 Verjans, 2000, Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells, Invest. Ophthalmol. Vis. Sci., 41, 2607 Visalli, 2002, Mutation of the herpes simplex virus-1 KOS UL45 gene reveals dose dependent effects on central nervous system growth, Arch. Virol., 147, 519, 10.1007/s007050200004 Vollstedt, 2004, Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1, J. Virol., 78, 3846, 10.1128/JVI.78.8.3846-3850.2004 Wander, 1980, Strain specificity of clinical isolates of herpes simplex virus, Arch. Ophthalmol., 98, 1458, 10.1001/archopht.1980.01020040310020 Ward, 2003, In vivo replication of an ICP34.5 second-site suppressor mutant following corneal infection correlates with in vitro regulation of eIF2 alpha phosphorylation, J. Virol., 77, 4626, 10.1128/JVI.77.8.4626-4634.2003 Whitley, 1996, Herpes simplex viruses, vol. 2, 2297 Whitley, 1993, Replication, establishment of latency, and induced reactivation of herpes simplex virus γ134.5 deletion mutants in rodent models, J. Clin. Invest., 2837, 10.1172/JCI116527 Williams, 1965, Experimental induction of disciform keratitis, Arch. Ophthalmol., 73, 112, 10.1001/archopht.1965.00970030114023 Wu, 1992, Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus, Curr. Topics Microbiol. Immunol., 179, 89 Yamada, 1991, The pathogenicity of ribonucleotide reductase (RR)—null mutants of herpes simplex virus type 1 in mice, J. Infect. Dis., 164, 1091, 10.1093/infdis/164.6.1091 Yan, 1998, Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea, Invest. Ophthalmol. Vis. Sci., 39, 1854 Zhao, 1998, Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection, Science, 279, 1344, 10.1126/science.279.5355.1344